Dave Kappos Speaks at the 2021 Leahy Institute of Advanced Patent Studies Conference
February 18, 2021
Cravath partner David J. Kappos spoke at the 6th annual Leahy Institute of Advanced Patent Studies Conference, which was hosted virtually by the Naples Roundtable from February 15‑17, 2021. Dave, who serves as chairman of the Roundtable’s advisory board, delivered opening remarks and moderated a panel that discussed whether the patent system in the United States encourages innovation and competition in key fields including artificial intelligence, healthcare diagnostics, and biopharmaceutical drug development.
Related Practices & Industries
Speakers
- Photo
-
-
J.D., 1990, University of California, Berkeley, School of Law
-
B.S., 1983, University of California, Davissumma cum laude
- New York
- California
- District of Columbia
Education
Admitted In
Related News & Insights
Deals & Cases
February 15, 2021
Cable One’s $2.2 Billion Acquisition of Hargray Communications
On February 15, 2021, Cable One, Inc. (“Cable One”) announced that it has entered into a definitive agreement to acquire the equity interests in Hargray Acquisition Holdings, LLC (“Hargray”) that it does not already own. The equity interests to be acquired by Cable One represent approximately 85% of Hargray on a fully diluted basis. The transaction, which implies a $2.2 billion total enterprise value for 100% of the equity interests of Hargray on a debt-free and cash-free basis, will expand Cable One’s presence into the Southeastern U.S. and enable Cable One to capitalize on Hargray’s experience and expertise in fiber expansion. Cravath is representing Cable One in connection with the transaction.
Deals & Cases
February 03, 2021
GW Pharmaceuticals plc’s $7.2 Billion Acquisition by Jazz Pharmaceuticals plc
On February 3, 2021, GW Pharmaceuticals plc (“GW”) and Jazz Pharmaceuticals plc (“Jazz”) announced that they have entered into a definitive agreement for Jazz to acquire GW, a global leader in developing, manufacturing and commercializing novel, regulatory approved therapeutics from its proprietary cannabinoid product platform to address a broad range of diseases for $220.00 per American Depositary Shares (ADS), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares for a total consideration of $7.2 billion. Cravath is representing GW in connection with the transaction.
Deals & Cases
January 11, 2021
Roku Acquires Quibi’s Global Content Distribution Rights
On January 8, 2021, Roku, Inc. announced that The Roku Channel will become the exclusive place to stream more than 75 premium shows and documentaries that Quibi, a streaming platform designed to deliver short‑form content, created in conjunction with Hollywood’s leading studios and production companies. Roku acquired the exclusive global distribution rights to Quibi’s award‑winning shows and will make the content available for free on an ad‑supported basis in 2021 to all Roku users. Following an internal restructuring by Quibi, Roku acquired Quibi Holdings, LLC, the company that holds all of Quibi’s content distribution rights. Cravath is representing Quibi in connection with the transaction.
Deals & Cases
January 06, 2021
AmerisourceBergen’s $6.5 Billion Acquisition of Alliance Healthcare Businesses from Walgreens Boots Alliance
On January 6, 2021, AmerisourceBergen Corporation and Walgreens Boots Alliance, Inc. announced strategic agreements under which AmerisourceBergen will acquire the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses for approximately $6.5 billion, comprised of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock. In addition, the companies have agreed to extend and expand their commercial agreements through 2029 to drive incremental growth. Cravath is representing AmerisourceBergen in connection with the transaction.
